% | $
Quotes you view appear here for quick access.

AVEO Pharmaceuticals, Inc. Message Board

  • taexpert928 taexpert928 May 23, 2013 7:48 PM Flag

    Astellas does not intend to fund any future studies of tivozanib, in renal cell cancer.

    I told you that there will be bad news soon. Most likely , CEO concealed the FDA info even from Astellas.
    Astells assessed the situation and decided not be a partner with a cheating company as AVEO.

    The next bad news will be that Astellas suing AVEO for not disclosing FDA info a year ago. And the next next news will be investigation of SEC for fraud.

    CEO thinks that he is working for CIA and should keep all FDA information as top secret. He is most likely will be investigated by SEC and fired by AVEO board.

    My posts helped me & convinced not to buy more AVEO shares when is was 2.7 today. I am happy.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Check my previous posts - told you that Astellas might walk from tivozanib. Anyone who continues to hold Aveo does so at their own risk - unfortunately, while tivo is a perfectly good drug, the odds of it making a dent in the PFE Inlyta/Sutent franchise is very low at this point.

1.34-0.03(-2.19%)Sep 3 3:59 PMEDT